In this two-day USP-BP joint workshop, speakers from industry, various international expert groups, the Medicines and Healthcare products Regulatory Agency (MHRA), U.S. Food & Drug Administration (U.S. FDA), U.S. Pharmacopeial Convention (USP), and the British Pharmacopoeia (BP) will discuss the use of Analytical Quality by Design concepts across the Analytical Procedure Lifecycle.
This workshop will include examples of specific case studies, experiences of members with various AQbD concepts, presentations at the cutting edge of AQbD advancements, and the latest regulator views on the developing science. The webinar will also include group panel discussions to continue and open the conversation to new participants and perspectives.
If you have any questions, please contact: email@example.com
Dates: September 30-October 1, 2021
Day 1: 8:00 a.m.–1:00 p.m. EDT (1:00-6:00 PM BST)
Day 2: 8:00 a.m. –12:00 p.m. EDT (1:00-5:00 PM BST)
Registration deadline: Friday, September 24, 11:59 p.m. EDT
Registration fee: $230 USD for the entire 2-day event